| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 17, 2013 | Pechala's Reports | Frantisek Pechala | OXYGEN BIOTHERAPEUTICS INC (OXBT) 12-months forecast | 1 | $15 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ALSE , CVM , CHTP , CYCC , CUR , OXBT -- DRUGS | 3 | $34.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: OXYGEN BIOTHERAP -- OXBT | 1 | $11.50 | | May 12, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Oxygen Biotherapeutics, Incorporation | 41 | $471.50 | | May 7, 2013 | Edison Investment Research | Mr. Robin Davison, Dr. Mick Cooper | TRANSGENE - KEY TIME APPROACHES | 12 | $10 |
|
View All Reports for OXBT ... |
|
|